단일 세포 분석 시장 : 제품 유형별, 최종 사용자별, 지역별 - 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2032년)

Single-Cell Analysis Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

US $ 4,995 ￦ 7,227,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,555,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 12,291,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 단일 세포 분석 시장을 심층적으로 분석하여 다각적인 역학 및 예측된 미래 동향에 대한 심층적인 통찰력을 제공합니다. 이 종합적인 보고서는 시장 개척, 촉진요인, 장애물, 신흥 패턴을 다루며 2024년부터 2032년까지 중요한 통계와 예측을 제공합니다.

주요 인사이트

• 단일 세포 분석 시장 규모(2024년) : 57억 달러
• 2032년 예상 시장 규모(2032년) : 245억 2,000만 달러
• 세계 시장 성장률(CAGR, 2024-2032년) : 23.17%

단일 세포 분석 시장 - 조사 범위:

이 시장은 세포의 이질성과 질병 메커니즘을 이해하는 데 필수적인 다양한 용도으로 구성되어 있습니다. 단일 세포 분석 기술은 연구자들이 복잡한 생물학적 시스템을 세포 수준에서 해부하여 세포 다양성, 유전자 발현 프로파일, 바이오마커 식별에 대한 통찰력을 제공할 수 있게 합니다. 이 시장은 암 연구, 면역학, 신경과학, 줄기세포 생물학 등 다양한 분야에서 단일 세포 분석의 적용이 확대되면서 크게 성장하고 있습니다. 또한, 단일 세포 분석 플랫폼의 기술 발전과 생명과학 연구에 대한 투자 증가가 시장 성장을 견인하고 있습니다.

시장 성장의 촉진요인

단일 세포 분석 시장의 성장을 가속하는 요인은 여러 가지가 있습니다. 암 및 신경 퇴행성 질환과 같은 질병에서 세포의 이질성을 해독하기 위한 고해상도 세포 분석 도구에 대한 수요 증가는 중요한 촉진요인입니다. 또한, 단일 세포 시퀀싱 기술의 발전으로 인해 단일 세포 분석의 적용 범위가 확대되고 있으며, 액적 기반 방법 및 공간적 전사체학(spatial transcriptomics) 등의 기술이 발전하고 있습니다. 또한, 학술 연구 기관, 제약사 및 기술 제공 업체 간의 협력은 단일 세포 분석 플랫폼의 기술 혁신을 촉진하고 시장 성장을 가속하고 있습니다.

시장 성장 억제요인

유망한 시장임에도 불구하고, 단일 세포 분석 시장은 몇 가지 문제에 직면해 있습니다. 높은 장비 비용과 데이터 분석의 복잡성은 특히 자원이 제한된 환경에서 단일 세포 분석 기술의 보급에 큰 장벽이 되고 있습니다. 또한, 단일 세포 데이터의 해석과 실험 프로토콜의 표준화는 여전히 연구자들에게 중요한 과제입니다. 또한, 데이터 재현성에 대한 우려와 강력한 품질 관리 조치의 필요성도 시장 성장을 어느 정도 저해하고 있습니다.

시장 기회

단일 세포 분석 시장은 기술 혁신과 성장 기회가 풍부합니다. 단일 세포 분리 기술의 발전과 멀티오믹스 접근법의 통합은 개인 맞춤형 의료 및 신약 개발에서 단일 세포 분석의 응용 분야를 확대할 수 있는 잠재력을 가지고 있습니다. 또한, 단일 세포 공간 프로파일링 기술의 출현은 다양한 병태생리에서 조직 미세환경과 세포 간 상호 작용을 연구할 수 있는 새로운 길을 열어줄 것입니다. 또한, 새로운 단일 세포 분석 분석 및 바이오마커 탐색 플랫폼을 개발하기 위해 기술 개발자와 제약회사와의 전략적 제휴는 시장 확대에 박차를 가할 가능성이 높습니다.

본 보고서에서 다룬 주요 질문들

• 단일 세포 분석 시장의 세계 성장을 가속하는 주요 요인은?
• 기술의 발전은 단일 세포 분석 기술의 개발 및 채택에 어떤 영향을 미쳤는가?
• 시장 진출기업의 주요 과제와 기회는 무엇인가?
• 가장 높은 성장을 기대할 수 있는 연구 분야와 치료 용도는?
• 시장 지위를 강화하고 연구자와 임상의 진화하는 요구에 대응하기 위해 주요 기업들은 어떤 전략을 채택하고 있는가?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장의 정의/범위/제한

제3장 시장 배경

• 시장 역학
• 시나리오 예측
• 기회 맵 분석
• 투자 실현 가능성 매트릭스
• PESTLE와 Porter's Five Forces 분석
• 규제 상황
• 지역별 모시장 전망

제4장 세계의 단일세포 분석 시장 분석

• 과거 시장 규모 금액 분석, 2019-2023년
• 현재 및 향후 시장 규모 금액 예측 : 2024-2032년
  • 전년대비 성장 동향 분석
  • 절대액 기회 분석

제5장 세계의 단일세포 분석 시장 분석 : 제품별

• 서론/주요 조사 결과
• 과거 시장 규모 금액 분석 : 제품별, 2019-2023년
• 현재 및 향후 시장 규모 금액 분석과 예측 : 제품별, 2024-2032년
  • 소모품
  • 기기
• 전년대비 성장 동향 분석 : 제품별, 2019-2023년
• 절대액 기회 분석 : 제품별, 2024-2032년

제6장 세계의 단일세포 분석 시장 분석 : 용도별

• 서론/주요 조사 결과
• 과거 시장 규모 금액 분석 : 용도별, 2019-2023년
• 현재 및 향후 시장 규모 금액 분석과 예측 : 용도별, 2024-2032년
  • 암
  • 면역학
  • 신경학
  • 줄기세포
  • 비침습적 산전 진단
  • 체외수정
  • 기타
• 전년대비 성장 동향 분석 : 용도별, 2019-2023년
• 절대액 기회 분석 : 용도별, 2024-2032년

제7장 세계의 단일세포 분석 시장 분석 : 워크플로우별

• 서론/주요 조사 결과
• 과거 시장 규모 금액 분석 : 워크플로우별, 2019-2023년
• 현재 및 향후 시장 규모 금액 분석과 예측 : 워크플로우별, 2024-2032년
  • 단세포 분리·라이브러리 조제
  • Downstream 분석
  • 데이터 분석
• 전년대비 성장 동향 분석 : 워크플로우별, 2019-2023년
• 절대액 기회 분석 : 워크플로우별, 2024-2032년

제8장 세계의 단일세포 분석 시장 분석 : 최종사용자별

• 서론/주요 조사 결과
• 과거 시장 규모 금액 분석 : 최종사용자별, 2019-2023년
• 현재 및 향후 시장 규모 금액 분석과 예측 : 최종사용자별, 2024-2032년
  • 학술기관 및 연구기관
  • 바이오테크놀러지 및 제약회사
  • 병원 및 진단 실험실
  • 기타
• 전년대비 성장 동향 분석 : 최종사용자별, 2019-2023년
• 절대액 기회 분석 : 최종사용자별, 2024-2032년

제9장 세계의 단일세포 분석 시장 분석 : 지역별

• 서론
• 과거 시장 규모 금액 분석 : 지역별, 2019-2023년
• 현재 시장 규모 금액 분석과 예측 : 지역별, 2024-2032년
  • 북미
  • 라틴아메리카
  • 유럽
  • 아시아태평양
  • 중동 및 아프리카
• 시장의 매력 분석 : 지역별

제10장 북미의 단일세포 분석 시장 분석 : 국가별

제11장 라틴아메리카의 단일세포 분석 시장 분석 : 국가별

제12장 유럽의 단일세포 분석 시장 분석 : 국가별

제13장 아시아태평양의 단일세포 분석 시장 분석 : 국가별

제14장 중동 및 아프리카의 단일세포 분석 시장 분석 : 국가별

제15장 주요 국가 단일세포 분석 시장 분석

• 미국
• 캐나다
• 브라질
• 멕시코
• 독일
• 영국
• 프랑스
• 스페인
• 이탈리아
• 중국
• 일본
• 한국
• 싱가포르
• 태국
• 인도네시아
• 호주
• 뉴질랜드
• GCC 국가
• 남아프리카공화국
• 이스라엘

제16장 시장 구조 분석

• 경쟁 대시보드
• 경쟁 벤치마킹
• 주요 기업의 시장 점유율 분석

제17장 경쟁 분석

• 경쟁 상세 정보
  • Thermo Fisher Scientific, Inc.
  • QIAGEN NV
  • Bio-Rad Laboratories Inc.
  • Illumina Inc.
  • Merck KGaA
  • Becton, Dickinson &Company
  • Fluidigm Corporation
  • 10x Genomics, Inc.
  • BGI
  • Novogene Corporation

제18장 전제조건과 사용된 두자어

제19장 조사 방법

LSH

영문 목차

영문목차

Persistence Market Research provides an in-depth analysis of the Single-Cell Analysis Market, offering detailed insights into its multifaceted dynamics and projected future trends. This comprehensive report encompasses market developments, driving forces, hurdles, and emerging patterns, furnishing crucial statistics and forecasts from 2024 to 2032.

Key Insights:

• Single-Cell Analysis Market Size (2024): USD 5.70 Billion
• Projected Market Value (2032): USD 24.52 Billion
• Global Market Growth Rate (CAGR 2024 to 2032): 23.17%

Single-Cell Analysis Market - Report Scope:

The market comprises various applications crucial for advancing our understanding of cellular heterogeneity and disease mechanisms. Single-cell analysis technologies enable researchers to dissect complex biological systems at the cellular level, offering insights into cellular diversity, gene expression profiles, and biomarker identification. The market is witnessing substantial growth driven by the expanding applications of single-cell analysis in various fields such as cancer research, immunology, neuroscience, and stem cell biology. Additionally, technological advancements in single-cell analysis platforms, coupled with increasing investments in life sciences research, are propelling market expansion.

Market Growth Drivers:

A multitude of factors propel the growth of the Single-Cell Analysis Market. The rising demand for high-resolution cellular analysis tools to decipher cellular heterogeneity in diseases like cancer and neurodegenerative disorders is a significant driver. Moreover, advancements in single-cell sequencing technologies, such as droplet-based methods and spatial transcriptomics, are expanding the scope of single-cell analysis applications. Furthermore, collaborations between academic research institutions, pharmaceutical companies, and technology providers are fostering innovation in single-cell analysis platforms, thereby driving market growth.

Market Restraints:

Despite its promising prospects, the Single-Cell Analysis Market faces certain challenges. High instrument costs and complexity in data analysis pose significant barriers to the widespread adoption of single-cell analysis technologies, particularly in resource-constrained settings. Moreover, the interpretation of single-cell data and standardization of experimental protocols remain key challenges for researchers. Additionally, concerns regarding data reproducibility and the need for robust quality control measures hinder market growth to some extent.

Market Opportunities:

The Single-Cell Analysis Market presents ample opportunities for innovation and growth. Advancements in single-cell isolation techniques, coupled with the integration of multi-omics approaches, hold promise for expanding the application spectrum of single-cell analysis in personalized medicine and drug discovery. Furthermore, the emergence of single-cell spatial profiling technologies offers new avenues for studying tissue microenvironments and cell-cell interactions in various pathological conditions. Moreover, strategic collaborations between technology developers and pharmaceutical companies to develop novel single-cell analysis assays and biomarker discovery platforms are likely to fuel market expansion.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Single-Cell Analysis Market globally?
• How are technological advancements influencing the development and adoption of single-cell analysis technologies?
• What are the major challenges and opportunities for market participants?
• Which research areas and therapeutic applications offer the highest growth potential?
• What strategies are leading companies employing to strengthen their market position and address the evolving needs of researchers and clinicians?

Competitive Intelligence and Business Strategy:

Key players in the global Single-Cell Analysis Market, including biotechnology companies, instrument manufacturers, and academic research institutions, focus on innovation, product differentiation, and strategic collaborations to maintain their competitive edge. Companies invest in developing cutting-edge single-cell analysis platforms that offer high sensitivity, throughput, and multiplexing capabilities. Additionally, emphasis on user-friendly software solutions for data analysis and visualization enhances the usability of single-cell analysis platforms, driving their adoption among researchers. Strategic partnerships with academic research centers and pharmaceutical companies facilitate technology validation and accelerate the translation of single-cell analysis findings into clinical applications.

Key Companies Profiled:

• Thermo Fisher Scientific Inc.
• Qiagen N.V
• Bio-Rad Laboratories Inc.
• Illumina Inc.
• Merck KGaA
• Becton, Dickinson & Company
• Fluidigm Corporation
• 10x Genomics Inc.
• BGI
• Novogene Corporation

Single-Cell Analysis Market Research Segmentation:

By Consumables

• Consumables

Reagents

Assay Kits

• Instruments
• Manual Instruments

Microscopes

Hemocytometers

Automated Instruments

Flow Cytometers

Next Generation Sequencing

PCR Systems

High-content Screening System

Cell Microarrays

Automated Cell Counters

By Application Type

• Cancer
• Immunology
• Neurology
• Stem Cell
• Non-invasive Prenatal Diagnosis
• In-vitro Fertilization
• Others

By Workflow

• Single Cell Isolation & Library Preparation
• Downstream Analysis
• Data Analysis

By End User

• Academic & Research Laboratories
• Biotechnology & Pharmaceutical Companies
• Hospitals & Diagnostic Laboratories
• Others

By Region

North America

Latin America

Europe

Asia Pacific

Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand-side Trends
• 1.3. Supply-side Trends
• 1.4. Technology Roadmap Analysis
• 1.5. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Market Background

• 3.1. Market Dynamics
  • 3.1.1. Drivers
  • 3.1.2. Restraints
  • 3.1.3. Opportunity
  • 3.1.4. Trends
• 3.2. Scenario Forecast
  • 3.2.1. Demand in Optimistic Scenario
  • 3.2.2. Demand in Likely Scenario
  • 3.2.3. Demand in Conservative Scenario
• 3.3. Opportunity Map Analysis
• 3.4. Investment Feasibility Matrix
• 3.5. PESTLE and Porter's Analysis
• 3.6. Regulatory Landscape
  • 3.6.1. By Key Regions
  • 3.6.2. By Key Countries
• 3.7. Regional Parent Market Outlook

4. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast, 2024-2032

• 4.1. Historical Market Size Value (US$ Mn) Analysis, 2019-2023
• 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2024-2032
  • 4.2.1. Y-o-Y Growth Trend Analysis
  • 4.2.2. Absolute $ Opportunity Analysis

5. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Product

• 5.1. Introduction / Key Findings
• 5.2. Historical Market Size Value (US$ Mn) Analysis By Product, 2019-2023
• 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product, 2024-2032
  • 5.3.1. Consumables
    • 5.3.1.1. Reagents
    • 5.3.1.2. Assay Kits
  • 5.3.2. Instruments
    • 5.3.2.1. Manual Instruments
    • 5.3.2.2. Microscopes
    • 5.3.2.3. Hemocytometers
    • 5.3.2.4. Automated Instruments
    • 5.3.2.5. Flow Cytometers
    • 5.3.2.6. Next Generation Sequencing
    • 5.3.2.7. PCR Systems
    • 5.3.2.8. High-content Screening System
    • 5.3.2.9. Cell Microarrays
    • 5.3.2.10. Automated Cell Counters
• 5.4. Y-o-Y Growth Trend Analysis By Product, 2019-2023
• 5.5. Absolute $ Opportunity Analysis By Product, 2024-2032

6. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Application

• 6.1. Introduction / Key Findings
• 6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2019-2023
• 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2024-2032
  • 6.3.1. Cancer
  • 6.3.2. Immunology
  • 6.3.3. Neurology
  • 6.3.4. Stem Cell
  • 6.3.5. Non-invasive Prenatal Diagnosis
  • 6.3.6. In-vitro Fertilization
  • 6.3.7. Others
• 6.4. Y-o-Y Growth Trend Analysis By Application, 2019-2023
• 6.5. Absolute $ Opportunity Analysis By Application, 2024-2032

7. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Workflow

• 7.1. Introduction / Key Findings
• 7.2. Historical Market Size Value (US$ Mn) Analysis By Workflow , 2019-2023
• 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Workflow , 2024-2032
  • 7.3.1. Single Cell Isolation & Library Preparation
  • 7.3.2. Downstream Analysis
  • 7.3.3. Data Analysis
• 7.4. Y-o-Y Growth Trend Analysis By Workflow , 2019-2023
• 7.5. Absolute $ Opportunity Analysis By Workflow , 2024-2032

8. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By End-user

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size Value (US$ Mn) Analysis By End-user, 2019-2023
• 8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-user, 2024-2032
  • 8.3.1. Academic & Research Laboratories
  • 8.3.2. Biotechnology & Pharmaceutical Companies
  • 8.3.3. Hospitals & Diagnostic Laboratories
  • 8.3.4. Others
• 8.4. Y-o-Y Growth Trend Analysis By End-user, 2019-2023
• 8.5. Absolute $ Opportunity Analysis By End-user, 2024-2032

9. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Region

• 9.1. Introduction
• 9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2019-2023
• 9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2024-2032
  • 9.3.1. North America
  • 9.3.2. Latin America
  • 9.3.3. Europe
  • 9.3.4. Asia Pacific
  • 9.3.5. MEA
• 9.4. Market Attractiveness Analysis By Region

10. North America Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
  • 10.2.1. By Country
    • 10.2.1.1. U.S.
    • 10.2.1.2. Canada
  • 10.2.2. By Product
  • 10.2.3. By Application
  • 10.2.4. By Workflow
  • 10.2.5. By End-user
• 10.3. Market Attractiveness Analysis
  • 10.3.1. By Country
  • 10.3.2. By Product
  • 10.3.3. By Application
  • 10.3.4. By Workflow
  • 10.3.5. By End-user
• 10.4. Key Takeaways

11. Latin America Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
  • 11.2.1. By Country
    • 11.2.1.1. Brazil
    • 11.2.1.2. Mexico
    • 11.2.1.3. Rest of Latin America
  • 11.2.2. By Product
  • 11.2.3. By Application
  • 11.2.4. By Workflow
  • 11.2.5. By End-user
• 11.3. Market Attractiveness Analysis
  • 11.3.1. By Country
  • 11.3.2. By Product
  • 11.3.3. By Application
  • 11.3.4. By Workflow
  • 11.3.5. By End-user
• 11.4. Key Takeaways

12. Europe Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
  • 12.2.1. By Country
    • 12.2.1.1. Germany
    • 12.2.1.2. U.K.
    • 12.2.1.3. France
    • 12.2.1.4. Spain
    • 12.2.1.5. Italy
    • 12.2.1.6. Rest of Europe
  • 12.2.2. By Product
  • 12.2.3. By Application
  • 12.2.4. By Workflow
  • 12.2.5. By End-user
• 12.3. Market Attractiveness Analysis
  • 12.3.1. By Country
  • 12.3.2. By Product
  • 12.3.3. By Application
  • 12.3.4. By Workflow
  • 12.3.5. By End-user
• 12.4. Key Takeaways

13. Asia Pacific Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
  • 13.2.1. By Country
    • 13.2.1.1. China
    • 13.2.1.2. Japan
    • 13.2.1.3. South Korea
    • 13.2.1.4. Singapore
    • 13.2.1.5. Thailand
    • 13.2.1.6. Indonesia
    • 13.2.1.7. Australia
    • 13.2.1.8. New Zealand
    • 13.2.1.9. Rest of Asia Pacific
  • 13.2.2. By Product
  • 13.2.3. By Application
  • 13.2.4. By Workflow
  • 13.2.5. By End-user
• 13.3. Market Attractiveness Analysis
  • 13.3.1. By Country
  • 13.3.2. By Product
  • 13.3.3. By Application
  • 13.3.4. By Workflow
  • 13.3.5. By End-user
• 13.4. Key Takeaways

14. MEA Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Country

• 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
  • 14.2.1. By Country
    • 14.2.1.1. GCC Countries
    • 14.2.1.2. South Africa
    • 14.2.1.3. Israel
    • 14.2.1.4. Rest of MEA
  • 14.2.2. By Product
  • 14.2.3. By Application
  • 14.2.4. By Workflow
  • 14.2.5. By End-user
• 14.3. Market Attractiveness Analysis
  • 14.3.1. By Country
  • 14.3.2. By Product
  • 14.3.3. By Application
  • 14.3.4. By Workflow
  • 14.3.5. By End-user
• 14.4. Key Takeaways

15. Key Countries Single-Cell Analysis Market Analysis

• 15.1. U.S.
  • 15.1.1. Pricing Analysis
  • 15.1.2. Market Share Analysis, 2024
    • 15.1.2.1. By Product
    • 15.1.2.2. By Application
    • 15.1.2.3. By Workflow
    • 15.1.2.4. By End-user
• 15.2. Canada
  • 15.2.1. Pricing Analysis
  • 15.2.2. Market Share Analysis, 2024
    • 15.2.2.1. By Product
    • 15.2.2.2. By Application
    • 15.2.2.3. By Workflow
    • 15.2.2.4. By End-user
• 15.3. Brazil
  • 15.3.1. Pricing Analysis
  • 15.3.2. Market Share Analysis, 2024
    • 15.3.2.1. By Product
    • 15.3.2.2. By Application
    • 15.3.2.3. By Workflow
    • 15.3.2.4. By End-user
• 15.4. Mexico
  • 15.4.1. Pricing Analysis
  • 15.4.2. Market Share Analysis, 2024
    • 15.4.2.1. By Product
    • 15.4.2.2. By Application
    • 15.4.2.3. By Workflow
    • 15.4.2.4. By End-user
• 15.5. Germany
  • 15.5.1. Pricing Analysis
  • 15.5.2. Market Share Analysis, 2024
    • 15.5.2.1. By Product
    • 15.5.2.2. By Application
    • 15.5.2.3. By Workflow
    • 15.5.2.4. By End-user
• 15.6. U.K.
  • 15.6.1. Pricing Analysis
  • 15.6.2. Market Share Analysis, 2024
    • 15.6.2.1. By Product
    • 15.6.2.2. By Application
    • 15.6.2.3. By Workflow
    • 15.6.2.4. By End-user
• 15.7. France
  • 15.7.1. Pricing Analysis
  • 15.7.2. Market Share Analysis, 2024
    • 15.7.2.1. By Product
    • 15.7.2.2. By Application
    • 15.7.2.3. By Workflow
    • 15.7.2.4. By End-user
• 15.8. Spain
  • 15.8.1. Pricing Analysis
  • 15.8.2. Market Share Analysis, 2024
    • 15.8.2.1. By Product
    • 15.8.2.2. By Application
    • 15.8.2.3. By Workflow
    • 15.8.2.4. By End-user
• 15.9. Italy
  • 15.9.1. Pricing Analysis
  • 15.9.2. Market Share Analysis, 2024
    • 15.9.2.1. By Product
    • 15.9.2.2. By Application
    • 15.9.2.3. By Workflow
    • 15.9.2.4. By End-user
• 15.10. China
  • 15.10.1. Pricing Analysis
  • 15.10.2. Market Share Analysis, 2024
    • 15.10.2.1. By Product
    • 15.10.2.2. By Application
    • 15.10.2.3. By Workflow
    • 15.10.2.4. By End-user
• 15.11. Japan
  • 15.11.1. Pricing Analysis
  • 15.11.2. Market Share Analysis, 2024
    • 15.11.2.1. By Product
    • 15.11.2.2. By Application
    • 15.11.2.3. By Workflow
    • 15.11.2.4. By End-user
• 15.12. South Korea
  • 15.12.1. Pricing Analysis
  • 15.12.2. Market Share Analysis, 2024
    • 15.12.2.1. By Product
    • 15.12.2.2. By Application
    • 15.12.2.3. By Workflow
    • 15.12.2.4. By End-user
• 15.13. Singapore
  • 15.13.1. Pricing Analysis
  • 15.13.2. Market Share Analysis, 2024
    • 15.13.2.1. By Product
    • 15.13.2.2. By Application
    • 15.13.2.3. By Workflow
    • 15.13.2.4. By End-user
• 15.14. Thailand
  • 15.14.1. Pricing Analysis
  • 15.14.2. Market Share Analysis, 2024
    • 15.14.2.1. By Product
    • 15.14.2.2. By Application
    • 15.14.2.3. By Workflow
    • 15.14.2.4. By End-user
• 15.15. Indonesia
  • 15.15.1. Pricing Analysis
  • 15.15.2. Market Share Analysis, 2024
    • 15.15.2.1. By Product
    • 15.15.2.2. By Application
    • 15.15.2.3. By Workflow
    • 15.15.2.4. By End-user
• 15.16. Australia
  • 15.16.1. Pricing Analysis
  • 15.16.2. Market Share Analysis, 2024
    • 15.16.2.1. By Product
    • 15.16.2.2. By Application
    • 15.16.2.3. By Workflow
    • 15.16.2.4. By End-user
• 15.17. New Zealand
  • 15.17.1. Pricing Analysis
  • 15.17.2. Market Share Analysis, 2024
    • 15.17.2.1. By Product
    • 15.17.2.2. By Application
    • 15.17.2.3. By Workflow
    • 15.17.2.4. By End-user
• 15.18. GCC Countries
  • 15.18.1. Pricing Analysis
  • 15.18.2. Market Share Analysis, 2024
    • 15.18.2.1. By Product
    • 15.18.2.2. By Application
    • 15.18.2.3. By Workflow
    • 15.18.2.4. By End-user
• 15.19. South Africa
  • 15.19.1. Pricing Analysis
  • 15.19.2. Market Share Analysis, 2024
    • 15.19.2.1. By Product
    • 15.19.2.2. By Application
    • 15.19.2.3. By Workflow
    • 15.19.2.4. By End-user
• 15.20. Israel
  • 15.20.1. Pricing Analysis
  • 15.20.2. Market Share Analysis, 2024
    • 15.20.2.1. By Product
    • 15.20.2.2. By Application
    • 15.20.2.3. By Workflow
    • 15.20.2.4. By End-user

16. Market Structure Analysis

• 16.1. Competition Dashboard
• 16.2. Competition Benchmarking
• 16.3. Market Share Analysis of Top Players
  • 16.3.1. By Regional
  • 16.3.2. By Product
  • 16.3.3. By Application
  • 16.3.4. By Workflow
  • 16.3.5. By End-user

17. Competition Analysis

• 17.1. Competition Deep Dive
  • 17.1.1. Thermo Fisher Scientific, Inc.
    • 17.1.1.1. Overview
    • 17.1.1.2. Product Portfolio
    • 17.1.1.3. Profitability by Market Segments
    • 17.1.1.4. Sales Footprint
    • 17.1.1.5. Strategy Overview
      • 17.1.1.5.1. Marketing Strategy
  • 17.1.2. QIAGEN NV
    • 17.1.2.1. Overview
    • 17.1.2.2. Product Portfolio
    • 17.1.2.3. Profitability by Market Segments
    • 17.1.2.4. Sales Footprint
    • 17.1.2.5. Strategy Overview
      • 17.1.2.5.1. Marketing Strategy
  • 17.1.3. Bio-Rad Laboratories Inc.
    • 17.1.3.1. Overview
    • 17.1.3.2. Product Portfolio
    • 17.1.3.3. Profitability by Market Segments
    • 17.1.3.4. Sales Footprint
    • 17.1.3.5. Strategy Overview
      • 17.1.3.5.1. Marketing Strategy
  • 17.1.4. Illumina Inc.
    • 17.1.4.1. Overview
    • 17.1.4.2. Product Portfolio
    • 17.1.4.3. Profitability by Market Segments
    • 17.1.4.4. Sales Footprint
    • 17.1.4.5. Strategy Overview
      • 17.1.4.5.1. Marketing Strategy
  • 17.1.5. Merck KGaA
    • 17.1.5.1. Overview
    • 17.1.5.2. Product Portfolio
    • 17.1.5.3. Profitability by Market Segments
    • 17.1.5.4. Sales Footprint
    • 17.1.5.5. Strategy Overview
      • 17.1.5.5.1. Marketing Strategy
  • 17.1.6. Becton, Dickinson & Company
    • 17.1.6.1. Overview
    • 17.1.6.2. Product Portfolio
    • 17.1.6.3. Profitability by Market Segments
    • 17.1.6.4. Sales Footprint
    • 17.1.6.5. Strategy Overview
      • 17.1.6.5.1. Marketing Strategy
  • 17.1.7. Fluidigm Corporation
    • 17.1.7.1. Overview
    • 17.1.7.2. Product Portfolio
    • 17.1.7.3. Profitability by Market Segments
    • 17.1.7.4. Sales Footprint
    • 17.1.7.5. Strategy Overview
      • 17.1.7.5.1. Marketing Strategy
  • 17.1.8. 10x Genomics, Inc.
    • 17.1.8.1. Overview
    • 17.1.8.2. Product Portfolio
    • 17.1.8.3. Profitability by Market Segments
    • 17.1.8.4. Sales Footprint
    • 17.1.8.5. Strategy Overview
      • 17.1.8.5.1. Marketing Strategy
  • 17.1.9. BGI
    • 17.1.9.1. Overview
    • 17.1.9.2. Product Portfolio
    • 17.1.9.3. Profitability by Market Segments
    • 17.1.9.4. Sales Footprint
    • 17.1.9.5. Strategy Overview
      • 17.1.9.5.1. Marketing Strategy
  • 17.1.10. Novogene Corporation
    • 17.1.10.1. Overview
    • 17.1.10.2. Product Portfolio
    • 17.1.10.3. Profitability by Market Segments
    • 17.1.10.4. Sales Footprint
    • 17.1.10.5. Strategy Overview
      • 17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

관련자료